About
Molecular Imaging Technologies
Areas of Focus
Categories
DiagnosticsMedical Imaging Technology
Clinical Trials (46)
View allTotal Trials
46
As Lead Sponsor
9
As Collaborator
37
Total Enrollment
3,256
By Phase
NA: 5EARLY_PHASE1: 5PHASE4: 5PHASE2: 12PHASE1: 5PHASE3: 9PHASE1/PHASE2: 1
By Status
COMPLETED: 19RECRUITING: 14ACTIVE_NOT_RECRUITING: 4UNKNOWN: 3TERMINATED: 3NOT_YET_RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline46 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT07115914Collaborator
Monitoring Patient Prostate Health Post Therapy
NANot yet recruiting
62 participants
Started: Aug 1, 2027 · Completed: Aug 1, 2028
NCT07011342Collaborator
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
NARecruiting
70 participants
Started: Oct 1, 2025 · Completed: Nov 30, 2028
NCT06862856Collaborator
Flotufolastat F 18 PET in Men with Very Low PSA Recurrence
N/ANot yet recruiting
50 participants
Started: May 20, 2025 · Completed: Dec 1, 2026
NCT05555550Collaborator
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_PHASE1Recruiting
30 participants
Started: Apr 29, 2025 · Completed: Sep 30, 2027
NCT06604442Lead Sponsor
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
PHASE4Completed
55 participants
Started: Dec 4, 2024 · Completed: Aug 29, 2025
Locations (1)
Headquarters
Oxford, UK
Map
Loading map...